ClinConnect ClinConnect Logo
Search / Trial NCT02669186

Effects of Anesthetic Technique on NK Cells

Launched by CEDARS-SINAI MEDICAL CENTER · Jan 27, 2016

Trial Information

Current as of August 19, 2025

Enrolling by invitation

Keywords

Analgesia Cancer Natural Killer Cell Opioid

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 - 80 years old of either gender
  • Diagnosis of abdominal tumor scheduled for exploratory laparotomy with study surgeon
  • Must be able to have an epidural
  • Exclusion Criteria:
  • ASA IV and above
  • Intolerance, allergy, or contraindication to use of either fentanyl or bupivacaine.
  • Significant coronary artery disease (abnormal stress test, myocardial infarction within the last 3 months)
  • Uncontrolled hypertension (BP \> 140/90)
  • Cardiac arrhythmias particularly prolonged QT syndrome
  • Drugs known to cause prolonged qT: class IA antiarrhythmics (quinidine, procainamide, dysopyramide), class III antiarrhythmics (sotalol, dofetalide, ibutalide, amiodarone), haloperidol, thioridazine, arsenic trioxide, HIV protease inhibitors, tricyclic antidepressants
  • Individuals with significant psychological disorders including: schizophrenia, mania, bipolar disorder or psychosis
  • Pregnant or lactating women
  • Morbid obesity (BMI \> 40 kg/m2) AND/OR weight \> 150 kg
  • Chronic renal failure ( creatinine \> 2.0 mg/dL)
  • Liver failure e.g., active cirrhosis
  • Alcohol or substance abuse within in the past 3 months
  • Uncorrected hypokalemia, hypomagnesemia, hypocalcemia (can be due to diuretics, mineralocorticoid use, laxatives)
  • Neuropathic pain
  • Chronic opioid consumption (\>30mg oxycodone or greater per day)
  • Cachexia from any cause
  • Systemic use of corticosteroids for greater than 2 weeks in the 6 months prior to surgery
  • HIV or other immunosuppressive condition
  • Preoperative INR \> 1.4 or platelet count \< 100
  • Sepsis or overlying skin cellulitis at epidural catheter insertion site
  • Inability to tolerate/unwillingness to have an epidural catheter for intraoperative/postoperative pain control for any reason, including prior back surgery resulting in distorted anatomy that precludes neuraxial anesthesia.
  • Inability to tolerate an epidural solution of either fentanyl or bupivacaine or needs another form of specialized pain control.

About Cedars Sinai Medical Center

Cedars-Sinai Medical Center is a renowned nonprofit academic medical center located in Los Angeles, California, recognized for its commitment to patient care, research, and education. As a leading institution in clinical trials, Cedars-Sinai harnesses innovative approaches to advance medical knowledge and improve treatment outcomes across various specialties. With a multidisciplinary team of experts, state-of-the-art facilities, and a patient-centered approach, Cedars-Sinai actively contributes to the development of novel therapies and interventions, ensuring the highest standards of clinical research while prioritizing patient safety and ethical considerations.

Locations

Los Angeles, California, United States

Patients applied

0 patients applied

Trial Officials

Roya Yumul, MD, PhD

Principal Investigator

Program Director, Department of Anesthesiology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials